Disclaimer

All health information news and images used on this page shared through RSS feed to MedSearch (“health data”) by the source owners who are solely responsible for its content and accuracy. MedSearch is not responsible for typographical or other errors or omissions or copyright and this lies with the owners of the source content.

Healthline

August 8, 2025

Published by Med Search on August 8, 2025

Categories

Healthline

French Fries Linked to Higher Diabetes Risk, but Potatoes Are Still Healthy

Share on PinterestNew research has found that consuming three or more servings of French fries per week is associated with a 20% increased risk. Kobus Louw/Getty […]

August 7, 2025

Published by Med Search on August 7, 2025

Categories

Healthline

Ticks Are Thriving In Warmer Temps, Experts Say. How to Protect Yourself

Share on PinterestExperts say climate change is a major factor in the increase and spread of ticks and tick-borne diseases. Karen Kasmauski/Getty Images Health officials report […]

August 7, 2025

Published by Med Search on August 7, 2025

Categories

Healthline

How RFK Jr.’s Move to Cut mRNA Vaccine Funding Impacts Public Health

Share on PinterestRFK Jr.’s decision to pull funding for mRNA vaccines could thwart public health responses to future pandemics. Anna Moneymaker/Getty Images HHS Secretary Robert F. […]

August 6, 2025

Published by Med Search on August 6, 2025

Categories

Healthline

Deion ‘Coach Prime’ Sanders Advocates for Bladder Cancer Screening After Close Call

Share on PinterestDeion ‘Coach Prime’ Sanders is raising awareness about getting screened for bladder cancer. Ed Zurga/Getty Images University of Colorado football coach Deion Sanders shared […]

Medscape

July 7, 2025

Published by Med Search on July 7, 2025

Categories

Medscape

Paclitaxel Matches Cisplatin HIPEC in Ovarian Cancer Paclitaxel Matches Cisplatin HIPEC in Ovarian Cancer

TOPLINE: Patients with advanced ovarian cancer undergoing interval cytoreductive surgery who received paclitaxel-based hyperthermic intraperitoneal chemotherapy (HIPEC) during surgery appeared to have comparable overall survival and […]

July 7, 2025

Published by Med Search on July 7, 2025

Categories

Medscape

Copeptin as a Prognostic Marker in Emergency Hyponatremia Copeptin as a Prognostic Marker in Emergency Hyponatremia

TOPLINE: Measuring copeptin levels in patients with hypotonic hyponatremia on emergency department (ED) admission provided key diagnostic insights. The copeptin to urinary sodium ratio more accurately […]

July 7, 2025

Published by Med Search on July 7, 2025

Categories

Medscape

T2D Tied to Mortality in Both Ischemic and Nonischemic HF T2D Tied to Mortality in Both Ischemic and Nonischemic HF

TOPLINE: Patients with type 2 diabetes (T2D) had approximately 20%-26% higher mortality rates following ischemic and nonischemic heart failure (HF) than those without diabetes, with similar […]

July 7, 2025

Published by Med Search on July 7, 2025

Categories

Medscape

Geographic Gaps in Maternity Care Cost Lives Geographic Gaps in Maternity Care Cost Lives

TOPLINE: Analysis of 14,772,210 live births revealed that counties designated as maternity care deserts faced significantly higher maternal mortality rates than those with full access to […]

FDA

September 2, 2025

Published by Med Search on September 2, 2025

Categories

Green Vitality dba Gr33n – 710151 – 08/25/2025

Delivery Method: Via Email Product: Drugs Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTER August 25, 2025 RE: 710151 Dear Privacy […]

August 29, 2025

Published by Med Search on August 29, 2025

Categories

July – September 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)

Ajovy (fremanezumab-vfrm) Emgality (galcanezumab-gnlm) Nurtec ODT (rimegepant) Ubrelvy (ubrogepant) Vyepti (eptinezumab-jjmr) Hypertension The “Warnings and Precautions”, “Adverse Reactions”, “Patient Counseling Information”, and “Patient Information” sections of […]

August 29, 2025

Published by Med Search on August 29, 2025

Categories

April – June 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)

Adcetris (brentuximab vedotin) Guillain-Barre syndrome FDA determined that no action is necessary at the time based on available information. Arzerra (ofatumumab)Gazyva (obinutuzumab)Riabni (rituximab-arrx)Rituxan (rituximab)Rituxan Hycela (rituximab […]

August 29, 2025

Published by Med Search on August 29, 2025

Categories

January – March 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)

Addyi (flibanserin) Drug hypersensitivity The “Contraindications”, “Warnings and Precautions”, “Adverse Reactions”, and “Medication Guide” sections of the labeling were updated in September 2021 to include hypersensitivity […]